Lv4
420 积分 2022-03-06 加入
Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors
2天前
已完结
A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin
29天前
已完结
Liposomes-mediated enhanced antitumor effect of docetaxel with BRD4-PROTAC as synergist for breast cancer chemotherapy/immunotherapy
1个月前
已完结
DX‐8951f: Summary of Phase I Clinical Trials
3个月前
已完结
Recent advances in trophoblast cell‐surface antigen 2 targeted therapy for solid tumors
3个月前
已完结
Flow Cytometry Protocols for Assessment of Platelet Function in Whole Blood
5个月前
已完结
Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis
6个月前
已完结
Monitoring Antiplatelet Aggregation In Vivo and In Vitro by Microtiter Plate Method
6个月前
已完结
The study of platelet aggregation using a microtiter plate reader ‒ methodological considerations
6个月前
已完结
Antibody-drug conjugates as targeted therapies: Are we there yet? A critical review of the current clinical landscape
9个月前
已完结
皖公网安备34019202002308
